imiquimod has been researched along with Necrosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Caimi, AT; Morilla, MJ; Perez, AP; Ramirez, C; Romero, EL | 1 |
Bao, YL; Huang, YX; Li, WL; Li, YX; Song, ZB; Sun, LG; Wang, Q; Yang, XG; Yu, CL; Zhang, WJ | 1 |
McLaughlin, PJ; Rogosnitzky, M; Zagon, IS | 1 |
Bult, H; De Meyer, GR; De Meyer, I; Martinet, W; Schrijvers, DM; Timmermans, JP | 1 |
Ahn, MY; Ahn, SG; Cheong, HH; Kwon, SM; Lee, J; Min, SK; Park, JH; Yoon, JH | 1 |
Adachi, S; Fujisawa, A; Heike, T; Kambe, N; Kanazawa, N; Miyachi, Y; Nakahata, T; Nishikomori, R; Sagara, J; Saito, M; Suda, T; Tanizaki, H | 1 |
6 other study(ies) available for imiquimod and Necrosis
Article | Year |
---|---|
Topics: Apoptosis; Humans; Imiquimod; Lipids; Liposomes; Melanoma; Necrosis; Skin | 2022 |
Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models.
Topics: Aminoquinolines; Animals; Cell Death; Cell Line; Cell Survival; Digitoxigenin; Disease Models, Animal; Female; Humans; Imiquimod; Mice; Mice, Inbred BALB C; Necrosis; Oxidative Stress; Psoriasis; Tetradecanoylphorbol Acetate | 2016 |
Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; DNA Replication; Epidermal Cells; Epidermis; Imiquimod; Mice; Mice, Inbred C57BL; Mice, Nude; Naltrexone; Narcotic Antagonists; Necrosis; Nucleic Acid Synthesis Inhibitors; Receptors, Opioid; Up-Regulation | 2010 |
Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Autophagy; Blotting, Western; Cytokines; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Imiquimod; Immunohistochemistry; Inflammation; Inflammation Mediators; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; NF-kappa B; Plaque, Atherosclerotic; Rabbits; Time Factors; Toll-Like Receptor 7; U937 Cells | 2012 |
Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
Topics: Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Humans; Imiquimod; Mouth Neoplasms; Necrosis; Toll-Like Receptor 7; Tumor Cells, Cultured | 2012 |
Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells.
Topics: Amino Acid Substitution; Aminoquinolines; Carrier Proteins; Cathepsin B; Cell Death; Cell Line; Dipeptides; Humans; Imiquimod; Inflammation; Lysosomes; Mitochondria; Models, Biological; Monocytes; Mutagenesis, Site-Directed; Mutation; Necrosis; NLR Family, Pyrin Domain-Containing 3 Protein; Recombinant Proteins; Transfection | 2007 |